Estimated marginal means from mixed model linear regression for patients using Rituximab.

Estimated marginal means (EM) after adjustment for age and gender during 1 year of treatment with Rituximab. EM: Estimated marginal means, P-values for comparison from mixed model regressions. *Result after lntransformationCRP: C-reactive protein mg/L ESR: Erythrocyte sedimentation rate mm/hour, TC: Total cholesterol mmol/L, HDL-c: High density lipoprotein cholesterol mmol/L, LDL-c: Low density lipoprotein cholesterol mmol/L, DAS28: Disease activity score 28 joints, USBM: Ultrasonography B-mode score, USPD: Ultrasonography Power doppler score, Syst BP: Systolic blood pressure mmHg, Diast BP: Diastolic mmHg blood pressure, AIx: Augmentation index %, PWV: Pulse wave velocity m/s, Rit: Rituximab, Toc: Tocilizumab, Aba: Abatacept. Estimated marginal means from mixed model linear regression for patients using Rituximab.